EHC Annual Report is Here! Explore the Highlights and Discover the Road Ahead
The European Haemophilia Consortium (EHC) shared an announcement on X:
”Our Annual Report 2024 is out! Explore EHC’s highlights, audited financials and our shared progress from the past year.”
Read the full report here.
In 2024, The European Haemophilia Consortium made significant progress not only in its own strategic planning but also through collaborations with key leaders in the field, such as the WFH and EAHAD, to strengthen its impact across the bleeding disorders community.
European Haemophilia Consortium President Miguel Crato shared his vision for the organization’s work, reaffirming its commitment to ensuring equal access to care for all:
‘Another key milestone in 2024 was the establishment of the EHC’s three strategic pillars: Education, Communication, and Advocacy -guiding our efforts to provide resources, foster dialogue, and champion patients’ rights. In particular, strengthening our communication efforts will allow us to better engage with our community, share vital information, and amplify the voices of our NMOs. Fostering partnerships with the World Federation of Hemophilia (WFH) and the European Association for Haemophilia and Allied Disorders (EAHAD) has amplified our collective impact.’
More on the latest news in the field of bleeding disorders in Hemostasis Today.
-
Jul 18, 2025, 12:18NBCA Hosts PEP Talk with Dr. Parks on Aging and Blood Clots
-
Jul 18, 2025, 12:14WFH Shares Powerful Patient Story on Access to Bleeding Disorders Treatment
-
Jul 18, 2025, 11:53HTRS Shines Spotlight on Faculty Powering the Future of Hemostasis and Thrombosis
-
Jul 16, 2025, 17:23ISTH 2025 Spotlight: HOPE-B Trial Highlights Sustained Efficacy of Gene Therapy for Hemophilia B
-
Jul 16, 2025, 15:00Together with Dr. Bethany Samuelson Bannow – Let’s Keep Hematology Moving Forward
-
Jul 19, 2025, 17:16Promising 85% Response: Ru-D Regimen Shows Hope for Adults with HLH
-
Jul 19, 2025, 16:16A Potential Link to Recurrent Pregnancy Loss: Monoclonal Anti-PF4 Antibodies' Role
-
Jul 19, 2025, 15:2115% Recanalization Rate During Transfer in Basilar Artery Occlusion: A Missed Opportunity?
-
Jul 18, 2025, 18:54New Issue Alert! Advances in Stroke: Vascular and Interventional Neurology 2025
-
Jul 16, 2025, 11:06Why Pain Feels Different for Everyone - The Guardian
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 13, 2025, 15:35World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 16, 2025, 10:24Salma Ismail: Honored to Be Invited By the EHA2025 as Part of Their Lighting the Flame Program
-
Jul 15, 2025, 17:002022 Chemistry Laureate Carolyn Bertozzi Shares Inspiring Advice for Young Scientists
-
Jul 15, 2025, 16:42A 200+ Year Historical Review of Women and Hemophilia: Shifting Perspectives
-
Jul 10, 2025, 18:25Dr. Carol Kasper: Honoring the Legacy
-
Jul 8, 2025, 08:26ASH and HVO Collaborate to Expand Hematology Training in LMICs